Skip to content

Clinical Trial for Aqua Serum Bomb

A prospective, open-label, one arm study to evaluate the safety and efficacy of Zayn & Myza Iceland Aqua Bomb Serum in healthy male or female volunteers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046351
Enrollment
15
Registered
2022-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: ZAYN & MYZA ICELAND AQUA BOMB SERUM: Dosage form: Liquid Usage: After Cleansing, take 1-2 pumps of serum on your palm. Dab and spread it all over your face and neck massage until compl

Sponsors

Believe Cosmetics Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Healthy Indian male/female healthy volunteers aged between 18-55 years. ii. Subjects with dry, rough, scaly, sore, and oily skin. iii. Willing to give Informed Consent Form. iv. Willing to complete the study assessments/questionnaires. v. Willing to avoid usage of his/her own moisturizers and face serum for at least one week before Commencement and during this study.

Exclusion criteria

Exclusion criteria: i. Pregnancy or breastfeeding. ii. Patients with pre-existing severe systemic disease necessitating long-term medication. iii. Patients with mild to severe Anaphylaxis reactions. iv. Evidence of significant uncontrolled co-morbid disease. v. History of cancer, including solid tumors, hematologic malignancies and carcinoma in situ vi. Any neurological (congenital or acquired), vascular or systemic disorder which could affect any of the efficacy assessments. vii. Participation in the current or previous clinical trial with any approved or investigational products during the past 1 month.

Design outcomes

Primary

MeasureTime frame
i. % Increase in skin hydration from baseline to each visit ii. % Decrease in Trans Epidermal Water Loss (TEWL) from baseline to each visit. iii. Improvement in skin texture. Timepoint: Day1 to Day5

Secondary

MeasureTime frame
To evaluate the consumer acceptance as well as their response towards the product through a feedback questionnaire.Timepoint: Day1 to Day5

Countries

India

Contacts

Public ContactDr Ashok Godavarthi

Radiant Research Services Pvt. Ltd

ashok@radiantresearch.in9880999297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026